{
    "Trade/Device Name(s)": [
        "ACCUSTEP Single and Multi-Strip Cassette/Dipstick DOA Screen Panels"
    ],
    "Submitter Information": "Applied DNA Technologies Inc.",
    "510(k) Number": "K061005",
    "Predicate Device Reference 510(k) Number(s)": [
        "K023946",
        "K020313"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "DIS",
        "JXM",
        "DIO",
        "LDJ",
        "DNK",
        "DJC",
        "DJR",
        "LCM",
        "LFG"
    ],
    "Summary Letter Date": "August 4, 2006",
    "Summary Letter Received Date": "August 8, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3100"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Barbiturate",
        "Benzodiazepines",
        "Cocaine",
        "Marijuana",
        "Methamphetamine",
        "Methadone",
        "Morphine",
        "Phencyclidine",
        "Nortriptyline"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay",
        "Colloidal gold detection"
    ],
    "Methodologies": [
        "Rapid qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "Panel",
        "Cassette",
        "Dipstick"
    ],
    "Document Summary": "FDA 510(k) summary for ACCUSTEP Single and Multi-Strip Cassette/Dipstick DOA Screen Panels for rapid chromatographic detection of drugs of abuse in urine.",
    "Indications for Use Summary": "Qualitative, simultaneous detection of up to ten drugs of abuse in human urine via rapid chromatographic immunoassay for healthcare professional use; preliminary screening only, requires confirmatory testing.",
    "fda_folder": "Toxicology"
}